Viveve(R) Announces Pricing of $13.5 Million Public Offering of Shares of Common Stock and NASDAQ Uplisting
4:46 PM June 14, 2016SUNNYVALE, CA–VIVE, VIVMF, (Marketwired – June 14, 2016) – Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE) (OTCQB: VIVMF), a medical technology company focused on women’s health, today announced the pricing of an underwritten public offering of 2,700,000 shares of its common stock at a price to the public of $5.00 per share, for gross proceeds of approximately $13.5 million. The net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $12.2
Read more